首页> 外文OA文献 >The Frequency of Low HER2 Expression in Breast Cancer and A Comparison of Prognosis Between Patients With HER2-Low and HER2-Negative Breast Cancer By HR Status

【2h】

The Frequency of Low HER2 Expression in Breast Cancer and A Comparison of Prognosis Between Patients With HER2-Low and HER2-Negative Breast Cancer By HR Status

机译：乳腺癌中低HER2表达的频率以及HR状态HER2-低和HER2阴性乳腺癌患者的预后比较

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Nanae Horisawa; Yayoi Adachi; Daiki Takatsuka; Kazuki Nozawa; Yuka Endo; Yuri Ozaki; Kayoko Sugino; Ayumi Kataoka; Haruru Kotani; Akiyo Yoshimura; Masaya Hattori; Masataka Sawaki; Hiroji Iwata;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients [J] . Tao Qin, Zhongyu Yuan, Roujun Peng, OncoTargets and therapy . 2013,第4期

机译：接受曲妥珠单抗治疗的HER2阳性乳腺癌患者的预后与HER2阴性乳腺癌患者的预后相当
2. High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer [J] . Nishimukai Arisa, Yagi Tomoko, Yanai Ayako, Clinical breast cancer . 2015,第3期

机译：Ki-67高表达和孕激素低表达可独立导致绝经后雌激素受体阳性和HER2阴性乳腺癌的患者预后更差。
3. Expression levels of some genes associated with tumor shrinkage by neoadjuvant endocrine therapy were paradoxically related with poor prognosis in patients with ER-positive/HER2-negative operable breast cancer [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：通过Neoadjuvant内分泌治疗与肿瘤收缩相关的一些基因的表达水平与ER阳性/ HER2-负操作乳腺癌患者的预后矛盾矛盾
4. Automatically diagnosing HER2 amplification status for breast cancer patients using large FISH images [C] . Salar Razavi, Gökhan Hatipoğlu, Hülya Yalçın Signal Processing and Communications Applications Conference . 2017

机译：使用大FISH图像自动诊断乳腺癌患者的HER2扩增状态
5. Boron Neutron Capture Therapy for HER2+ breast cancers: A feasibility study evaluating BNCT for potential role in breast conservation therapies. [D] . Jenkins, Peter Anthony. 2012

机译：HER2 +乳腺癌的硼中子捕获疗法：评估BNCT在乳腺癌保护疗法中潜在作用的可行性研究。
6. HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients [O] . Tao Qin, Zhongyu Yuan, Roujun Peng, 2013

机译：接受曲妥珠单抗治疗的HER2阳性乳腺癌患者的预后与HER2阴性乳腺癌患者的预后相当
7. HER2-positive breast cancer patients receiving trastuzumab treatment obtain prognosis comparable with that of HER2-negative breast cancer patients [O] . Tao Qin 2013

机译：HER2阳性乳腺癌患者接受曲妥珠单抗治疗可与HER2阴性乳腺癌患者的预后相当

The Frequency of Low HER2 Expression in Breast Cancer and A Comparison of Prognosis Between Patients With HER2-Low and HER2-Negative Breast Cancer By HR Status

著录项

引文网络

相似文献

相关主题

期刊订阅